A Phase 2, Uncontrolled, Two-stage, Dose-escalations Cohort Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Clinical activity of OMS721 in Adults with Thrombotic Microangiopathies
Clinical Trial Grant
Administered By
Medicine, Hematology
Awarded By
Omeros
Start Date
August 1, 2014
End Date
July 31, 2023
Administered By
Medicine, Hematology
Awarded By
Omeros
Start Date
August 1, 2014
End Date
July 31, 2023